Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 236.00
Bid: 233.00
Ask: 236.00
Change: 5.00 (2.16%)
Spread: 3.00 (1.288%)
Open: 236.00
High: 236.00
Low: 231.00
Prev. Close: 231.00
GFRD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 Update

31 Mar 2020 07:00

RNS Number : 1332I
Galliford Try Holdings PLC
31 March 2020
 

GALLIFORD TRY HOLDINGS PLC

COVID-19 UPDATE

31 MARCH 2020

 

Galliford Try, one of the UK's leading construction groups, provides an operational update on the impact of the Covid-19 pandemic on its business and the measures it is taking in response.

The health and safety of our staff, subcontractors, suppliers, clients and the public is paramount, and in compliance with Government guidance we are implementing additional measures to protect and mitigate risk.

Management response

Across the Group we are working with the NHS and others to assist and support them to increase capacity to meet the current challenges and immediate needs.

In accordance with Government advice on construction works and the Standard Operating Procedures issued by the Construction Leadership Council, we have risk assessed every one of our construction sites and modified or curtailed site activities to ensure that no work is undertaken if we are unable to fully comply with the hygiene and social distancing guidelines or if our people cannot travel safely to work. Sites that remain operating do so under the strictest of parameters, as set out by the Construction Leadership Council, in conjunction with our own rigorous risk assessments. In addition, where specific client instructions have been received, we are carefully managing temporary closure of sites to leave them in a safe state whilst they are closed.

Where projects are temporarily suspended, we are planning for the speedy resumption of works as soon as conditions allow. We are continuing to monitor the situation and liaise with our clients, and support our supply chain, on all projects.

We have already taken a number of actions to manage costs in the business and conserve cash, and we will continue to review our resources to match business requirements. The business expects to make use of the Government Coronavirus Job Retention Scheme and other measures announced by the Government in response to the pandemic. The Group is committed to fully supporting all staff and has implemented furloughing of personnel where appropriate.

The scale and duration of disruption to our activities, and the impact on our supply chain, is not yet clear. For this reason, it is too early to quantify the potential impact of Covid-19 on revenue and operating profit, and hence it is not possible at the present time to provide guidance for our financial years ending 30 June 2020 and 30 June 2021.

Balance sheet and dividend

Galliford Try remains a well-capitalised business with no debt or bank covenants. The Government is continuing to support our sector, for example through the Cabinet Office Procurement Policy Note which provides guidance on payment by public bodies during the Covid-19 outbreak, and 83% of our order book is in the public and regulated sectors. The Group's cash levels remain in line with management's expectations, with average month end cash for the second half of the financial year to 30 June 2020 expected to remain over £100m, and the Group continues to hold a PPP portfolio of £39m. The Group is implementing additional measures, including the furloughing of personnel referred to above, to manage its working capital and preserve its liquidity through this period of disruption. The Board is continuing to monitor developments closely and is confident that the Group is well placed to withstand the current period of uncertainty and positioned to deliver as the market recovers. In the prevailing circumstances the Board considers it prudent to cancel payment of the interim dividend of 1.0p per share announced on 12 March 2020. The Board will at the appropriate time consider paying the interim dividend with the final dividend.

 

Bill Hocking, Chief Executive of Galliford Try, commented: "These are extremely challenging times and our upmost priority remains the health and safety of our employees and the wider community. We are a well-capitalised business, taking all necessary steps through the present circumstances to ensure that we are well placed to support economic recovery."

 

 

For further enquiries please contact:

 

 

Galliford Try:

Bill Hocking, Chief Executive

Andrew Duxbury, Finance Director

Kevin Corbett, General Counsel & Company Secretary

 

01895 855001

Tulchan Communications:

James Macey White, Giles Kernick, Amber Ahluwalia

 

0207 353 4200

 

 

 

This announcement contains inside information for the purposes of article 7 of EU Regulation 596/2014. The person responsible for making this announcement on behalf of Galliford Try is Kevin Corbett, General Counsel & Company Secretary.

 

Galliford Try is a trading name of Galliford Try Holdings plc, a leading UK construction group listed on the London Stock Exchange. Operating as Galliford Try and Morrison Construction, the group carries out building and infrastructure projects with clients in the public, private and regulated sectors across the UK.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDBBLLXBXLXBBX
Date   Source Headline
13th Jun 20247:00 amRNSContract
31st May 20244:00 pmRNSTotal Voting Rights
31st May 20247:00 amRNSContract
23rd May 20247:00 amRNSCapital Markets Event
30th Apr 20244:00 pmRNSTotal Voting Rights
23rd Apr 20244:00 pmRNSDirector/PDMR Shareholding
10th Apr 20245:00 pmRNSHolding(s) in Company
5th Apr 202411:00 amRNSTotal Voting Rights
28th Mar 20247:00 amRNSDirectorate Change
8th Mar 20244:00 pmRNSDirector/PDMR Shareholding
6th Mar 20247:00 amRNSHalf-year Report
4th Mar 20244:00 pmRNSTotal Voting Rights
1st Mar 20247:00 amRNSDirectorate Change
26th Feb 20246:03 pmRNSBlock listing Interim Review
22nd Feb 20247:00 amRNSContract
17th Jan 20247:00 amRNSTrading Statement
30th Nov 20234:00 pmRNSTotal Voting Rights
17th Nov 20237:00 amRNSCompletion of Share Buyback Programme
16th Nov 20234:30 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSTransaction in Own Shares
10th Nov 20233:00 pmRNSResult of AGM
10th Nov 20237:00 amRNSAGM Statement
9th Nov 20237:00 amRNSAcquisition
8th Nov 20237:00 amRNSDirectorate Change
7th Nov 20237:00 amRNSContract
2nd Nov 20235:51 pmRNSTotal Voting Rights
1st Nov 20237:00 amRNSTransaction in Own Shares
30th Oct 20237:00 amRNSTransaction in Own Shares
27th Oct 20237:00 amRNSTransaction in Own Shares
26th Oct 20239:14 amRNSTransaction in Own Shares
23rd Oct 202311:05 amRNSDirectorate Change
18th Oct 20237:00 amRNSTransaction in Own Shares
13th Oct 20237:00 amRNSTransaction in Own Shares
6th Oct 20233:30 pmRNSAnnual Financial Report
3rd Oct 202310:15 amRNSEmployee Share Trust Trading Plan
2nd Oct 202310:30 amRNSTotal Voting Rights
28th Sep 20233:05 pmRNSDirector/PDMR Shareholding
28th Sep 20233:00 pmRNSDirector/PDMR Shareholding
26th Sep 20234:30 pmRNSDirector/PDMR Shareholding
25th Sep 20234:15 pmRNSDirector/PDMR Shareholding
22nd Sep 20233:00 pmRNSHolding(s) in Company
21st Sep 20232:30 pmRNSBlock listing Interim Review
20th Sep 20237:00 amRNSFinal Results
12th Sep 20237:00 amRNSTransaction in Own Shares
8th Sep 20237:00 amRNSTransaction in Own Shares
7th Sep 20237:00 amRNSTransaction in Own Shares
6th Sep 20237:00 amRNSTransaction in Own Shares
4th Sep 20237:00 amRNSTransaction in Own Shares
1st Sep 202310:30 amRNSTotal Voting Rights
1st Sep 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.